Overcoming resistance in advanced urothelial carcinoma: mechanisms of escape from antibody-drug conjugates and FGFR3 inhibition
Brandon Wummer(Emory University), Jacqueline T. Brown(Emory University), Shahid Ahmed(Emory University), Bradley Curtis Carthon(Emory University), Mehmet Asım Bilen(Emory Healthcare), Michael W. Schwartz(University of Washington), Vikram M. Narayan(Emory University), Jordan Ciuro(Emory University), Shreyas Joshi
Cited by 1
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Identification of targets of leptin action in rat hypothalamus.
|Journal of Clinical Investigation|1996|1.5k
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
Is the Energy Homeostasis System Inherently Biased Toward Weight Gain?
|Diabetes|2003|350